Drug class |
Preferred indications |
Contraindications | |
Diuretics | |||
Thiazide and thiazide-like diuretics |
Isolated systolic hypertension (in the elderly), HF, hypertension in Black patients |
Gout, pregnancy,a hypercalcemia,a hyponatremia, hypokalemiaa | |
Aldosterone antagonists |
HF, prior MI, prevention of AF (may be considered) |
Hyperkalemia | |
Beta‑blockers |
Angina pectoris, prior MI, HF, aortic aneurysm, pregnancy, prevention of AF (may be considered), ventricular rate control in AF |
Asthma, second-degree/third-degree AV block, peripheral artery disease,a metabolic syndrome,a IGT,a COPD (except for beta-blockers with vasodilation effects),a athletes or physically active patients | |
Calcium channel blockers | |||
Dihydropyridines |
LV hypertrophy, asymptomatic atherosclerosis, angina pectoris, peripheral artery disease, isolated systolic hypertension (in the elderly), pregnancy, hypertension in Black patients |
Tachyarrhythmia,a HFa | |
Verapamil and diltiazem |
Ventricular rate control in AF, LV hypertrophy, asymptomatic atherosclerosis, angina pectoris, peripheral artery disease, isolated systolic hypertension (in the elderly), metabolic syndrome, pregnancy, hypertension in Black patients |
Second-degree/third-degree AV block, severe LV dysfunction, HF | |
ACEIs |
LV hypertrophy, asymptomatic atherosclerosis, microalbuminuria, renal dysfunction, prior MI, HF, prevention of AF (may be considered), end-stage renal failure/proteinuria, peripheral artery disease, metabolic syndrome, DM |
Pregnancy, angioedema, hyperkalemia, bilateral renal artery stenosis, renal artery stenosis of a solitary functioning kidney | |
ARBs |
LV hypertrophy, microalbuminuria, renal dysfunction, previous MI, HF, prevention of AF (may be considered), end-stage renal failure/proteinuria, metabolic syndrome, DM |
Pregnancy, hyperkalemia, bilateral renal artery stenosis, renal artery stenosis of a solitary functioning kidney | |
a Relative contraindications. | |||
Adapted from Can J Cardiol. 2018;34(5):506-525, Eur Heart J. 2018; 29(33):3021-3104, and Eur Heart J. 2013;34(28):2159-219. | |||
ACEI, angiotensin-converting enzyme inhibitor; AF, atrial fibrillation; ARB, angiotensin receptor blocker; AV, atrioventricular; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HF, heart failure; IGT, impaired glucose tolerance; LV, left ventricle; MI, myocardial infarction. |